Future Perspectives for the Ventilator-Associated Pneumonia (VAP) Market in Critical Care Medicine
The Ventilator-associated pneumonia (VAP) market is experiencing a substantial increase in volume, projected to reach USD 3,137.49 million by 2035, growing at a compound annual growth rate (CAGR) of 10.2%. This growth is driven by an urgent need for effective strategies to manage VAP in critical care settings. The rise in the number of patients requiring mechanical ventilation, coupled with...
0 Commenti 0 condivisioni 204 Views 0 Anteprima